Aminoglutethimide

氨鲁米特

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAminoglutethimide
Drug Alias Nameaminoglutetimida氨苯哌酮氨基导眠能Aminoglutethimidum氨格鲁米特 +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAromatase inhibitors
TargetsAromatase
Therapy Area/IndicationsPituitary ACTH HypersecretionBreast Neoplasms
Global Approved IndicationsPituitary ACTH HypersecretionBreast Neoplasms
Approved Indications in ChinaPituitary ACTH HypersecretionBreast Neoplasms
Original Approved Country/TerritoryUnited States
Original Approved Date1980/10/29
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNantong Jinghua Pharmaceutical Co Ltd
Inactive CompaniesNovartis Pharma Ag
Active IndicationsPituitary ACTH HypersecretionBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL02BG01
Related LinksWikipediaDrugBankKEGG